163 related articles for article (PubMed ID: 21178146)
1. Therapeutic effect of stealth-type polymeric nanoparticles with encapsulated betamethasone phosphate on experimental autoimmune uveoretinitis.
Sakai T; Ishihara T; Higaki M; Akiyama G; Tsuneoka H
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1516-21. PubMed ID: 21178146
[TBL] [Abstract][Full Text] [Related]
2. Treatment of experimental autoimmune uveoretinitis with poly(lactic acid) nanoparticles encapsulating betamethasone phosphate.
Sakai T; Kohno H; Ishihara T; Higaki M; Saito S; Matsushima M; Mizushima Y; Kitahara K
Exp Eye Res; 2006 Apr; 82(4):657-63. PubMed ID: 16360654
[TBL] [Abstract][Full Text] [Related]
3. Treatment of experimental arthritis with stealth-type polymeric nanoparticles encapsulating betamethasone phosphate.
Ishihara T; Kubota T; Choi T; Higaki M
J Pharmacol Exp Ther; 2009 May; 329(2):412-7. PubMed ID: 19244548
[TBL] [Abstract][Full Text] [Related]
4. Effect of betamethasone phosphate loaded polymeric nanoparticles on a murine asthma model.
Matsuo Y; Ishihara T; Ishizaki J; Miyamoto K; Higaki M; Yamashita N
Cell Immunol; 2009; 260(1):33-8. PubMed ID: 19716124
[TBL] [Abstract][Full Text] [Related]
5. Polymeric nanoparticles encapsulating betamethasone phosphate with different release profiles and stealthiness.
Ishihara T; Kubota T; Choi T; Takahashi M; Ayano E; Kanazawa H; Higaki M
Int J Pharm; 2009 Jun; 375(1-2):148-54. PubMed ID: 19481700
[TBL] [Abstract][Full Text] [Related]
6. Treatment of experimental autoimmune uveoretinitis with atorvastatin and lovastatin.
Kohno H; Sakai T; Saito S; Okano K; Kitahara K
Exp Eye Res; 2007 Mar; 84(3):569-76. PubMed ID: 17208229
[TBL] [Abstract][Full Text] [Related]
7. Treatment of experimental autoimmune uveoretinitis with peroxisome proliferator-activated receptor α agonist fenofibrate.
Osada M; Sakai T; Kuroyanagi K; Kohno H; Tsuneoka H
Mol Vis; 2014; 20():1518-26. PubMed ID: 25489225
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs in retina during development of experimental autoimmune uveoretinitis in rats.
Watanabe T; Keino H; Kudo A; Sato Y; Okada AA
Br J Ophthalmol; 2016 Mar; 100(3):425-31. PubMed ID: 26541434
[TBL] [Abstract][Full Text] [Related]
9. Effect of sex hormones on experimental autoimmune uveoretinitis (EAU).
Buggage RR; Matteson DM; Shen DF; Sun B; Tuaillon N; Chan CC
Immunol Invest; 2003 Nov; 32(4):259-73. PubMed ID: 14603994
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory effect of angiotensin type 1 receptor antagonist on endotoxin-induced uveitis in rats.
Miyazaki A; Kitaichi N; Ohgami K; Iwata D; Jin XH; Iwabuchi K; Morohashi T; Ohno S; Onoé K
Graefes Arch Clin Exp Ophthalmol; 2008 May; 246(5):747-57. PubMed ID: 18087711
[TBL] [Abstract][Full Text] [Related]
11. Caffeic acid phenethyl ester lessens disease symptoms in an experimental autoimmune uveoretinitis mouse model.
Choi JH; Roh KH; Oh H; Park SJ; Ha SM; Kang MS; Lee JH; Jung SY; Song H; Yang JW; Park S
Exp Eye Res; 2015 May; 134():53-62. PubMed ID: 25795054
[TBL] [Abstract][Full Text] [Related]
12. Treatment of experimental autoimmune uveoretinitis with intravitreal injection of tacrolimus (FK506) encapsulated in liposomes.
Zhang R; He R; Qian J; Guo J; Xue K; Yuan YF
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3575-82. PubMed ID: 20164461
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic role of retinal microglia in experimental uveoretinitis.
Rao NA; Kimoto T; Zamir E; Giri R; Wang R; Ito S; Pararajasegaram G; Read RW; Wu GS
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):22-31. PubMed ID: 12506051
[TBL] [Abstract][Full Text] [Related]
14. Intraocular injection of tamoxifen-loaded nanoparticles: a new treatment of experimental autoimmune uveoretinitis.
de Kozak Y; Andrieux K; Villarroya H; Klein C; Thillaye-Goldenberg B; Naud MC; Garcia E; Couvreur P
Eur J Immunol; 2004 Dec; 34(12):3702-12. PubMed ID: 15517615
[TBL] [Abstract][Full Text] [Related]
15. Effects of mycophenolate mofetil on nasal mucosal tolerance induction.
Dick AD; Kreutzer B; Laliotou B; Forrester JV
Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):835-40. PubMed ID: 9538893
[TBL] [Abstract][Full Text] [Related]
16. Treatment of experimental autoimmune uveoretinitis with intravitreal injection of infliximab encapsulated in liposomes.
Zhang R; Qian J; Li X; Yuan Y
Br J Ophthalmol; 2017 Dec; 101(12):1731-1738. PubMed ID: 28986343
[TBL] [Abstract][Full Text] [Related]
17. Treatment of experimental arthritis with poly(D, L-lactic/glycolic acid) nanoparticles encapsulating betamethasone sodium phosphate.
Higaki M; Ishihara T; Izumo N; Takatsu M; Mizushima Y
Ann Rheum Dis; 2005 Aug; 64(8):1132-6. PubMed ID: 15695536
[TBL] [Abstract][Full Text] [Related]
18. [Expression of suppressor of cytokine signaling in retina of experimental autoimmune uveoretinitis].
Wang H; Zhou ZC; Peng XY; Zhao M
Zhonghua Yan Ke Za Zhi; 2008 Oct; 44(10):876-82. PubMed ID: 19176113
[TBL] [Abstract][Full Text] [Related]
19. Photoreceptor mitochondrial oxidative stress in early experimental autoimmune uveoretinitis.
Rajendram R; Saraswathy S; Rao NA
Br J Ophthalmol; 2007 Apr; 91(4):531-7. PubMed ID: 17035279
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of intravitreal injection of vasoactive intestinal peptide-loaded liposomes on experimental autoimmune uveoretinitis.
Camelo S; Lajavardi L; Bochot A; Goldenberg B; Naud MC; Brunel N; Lescure B; Klein C; Fattal E; Behar-Cohen F; de Kozak Y
J Ocul Pharmacol Ther; 2009 Feb; 25(1):9-21. PubMed ID: 19232006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
